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INTRODUCTION 
Botulinum neurotoxin (BoNT; 150 kDa) is produced by an anaerobic gram-
positive bacterium Clostridium botulinum. BoNTs are classified as the serotypes 
A-G. Serotypes A, B, E and F are mainly responsible for human botulism, 
whereas serotypes C and D cause animal and avian botulism. Three types 
botulism are known: food-borne botulism, the most common case of poisoning 
due to an oral ingestion of the toxin with polluted foods; infant-botulism, toxin 
production by colonized bacterium in the gastrointestinal tract of the infant; and 
wound-botulism, entrance of the toxin through a wound. Food-borne botulism 
occurs of human every 2 or 3 years in Japan, although the case of death has never 
been reported since 1986. On the other hand, sporadic and massive outbreaks of 
cattle botulism have occurred worldwide in recent years. (Cobb et al., 2002; 
Martin, 2003; Steinman et al., 2007). In Japan, one to 5 cases of cattle botulism have 
been reported every years, causing large economic losses in dairy and beef cattle 
farming. 
In culture supernatant and contaminated foods, the BoNT exists as a part 
of the toxin complex (TC). The TC consists of BoNT and some nontoxic proteins, 
which are designated nontoxic nonhemagglutinin (NTNHA) and some 
hemagglutinin (HA) subcomponents. The HA is composed of three 
subcomponents having molecular masses of 70, 33 and 17 kDa (HA-70, HA-33 
and HA-17, respectively). Serotype A-D strains produce the M-TC 
(BoNT/NTNHA complex) and L-TC (M-TC/HAs complex) in the culture medium, 
while serotype E and F strains produce only M-TC.  
After oral ingestion of TCs, the TCs are absorbed through intestinal 
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epithelial cells into bloodstream, then BoNT is separated from TC due to blood 
pH. The BoNT reaches the neuromuscular junctions. Then BoNT enters the 
presynaptic nerve terminus via receptor-mediated endocytosis and cleaves the 
proteins involved in the vesicular fusion machinery by its protease activity, 
thereby blocking release of neurotransmitters acetylcholine. These processes 
result in a nerve paralysis. 
   Since the discovery of the botulinum TC in the culture fluid of serotype A 
bacterium in 1946 (Lamanna et al., 1946), many researchers have been 
investigating the botulinum TC to clarify its structure and function. Especially, 
the BoNT protein is the most investigated one among the botulinum TC 
components, because this protein is thought to be the main toxic molecule in TC. 
However, when the BoNT is administered orally to the mice, most of the ingested 
animals survive; even though the intraperitoneal administration of the BoNT 
displays potent lethal activity to the mice. Meanwhile the botulinum TC exerts 
the potent lethal activity in both cases when administered orally and 
intraperitoneal. Therefore, the nontoxic proteins in the botulinum TC are 
essential for the oral toxicity. In fact, a recent report demonstrated that the 
reconstituted complex consisted of BoNT and NTNHA exhibited dramatic 
resistance to proteolysis by pepsin or trypsin at high concentrations, despite the 
fact that the BoNT and NTNHA proteins were both easily degraded (Miyata et 
al., 2009) To reveal the mechanism of the food-borne botulism, it is important to 
clarify the structure and the function of the nontoxic proteins of the botulinum 
TC. Nevertheless, the structure and function of the botulinum TC remain unclear. 
In particular, three-dimensional structure of the NTNHA protein was not 
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uncovered because of the difficulty to prepare the NTNHA protein crystal, 
although the crystal structures of other TC components were already revealed.  
Recently, Miyata et al. (2012) succeeded in the crystallization of the 
botulinum NTNHA protein. Additionally, Inui et al. (2012) reported that NTNHA 
molecule consists of three domains, and that the NTNHA and BoNT share similar 
protein structure. These findings led the author to speculate that NTNHA plays 
some roles in the delivery of TC from gastrointestinal tract to nerve endings. In 
this study, the author focused on the structure and function of the NTNHA, and 
described the thesis consists of three chapters here. In the Chapter 1, to 
understand the crystal and a solution structure features of the NTNHA. In the 
Chapter 2, to investigate the biological activity about NTNHA using cultured 
intestinal epithelium cell. In the Chapter 3, to investigate the biological activity 
of NTNHA using cultured epithelium cells and endothelial cells in the in vitro 
experiments.        
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1. INTRODUCTION 
Botulinum neurotoxin (BoNT; 150 kDa), produced in seven distinct serotypes (A–
G) by an anaerobic gram-positive bacterium Clostridium botulinum, is the most 
potent toxin in nature. BoNT enters humans and animals via one of three 
pathways: toxin production by colonized bacterium in the gastrointestinal tract 
of the infant, entrance of the toxin through a wound, and oral ingestion of the 
toxin with polluted foods. Among these, the latter pathway, namely food-borne 
botulism, is the most frequent. In any case, BoNT eventually enters neuronal cells 
at neuromuscular junctions, where it cleaves a specific protein involved in 
neurotransmitter release, causing paralysis of the muscle. 
Pure BoNT is highly susceptible to proteolysis, and it easily degrades into 
inactive small fragments in the digestive environment (Miyata et al., 2009). Thus 
pure BoNT exhibits only weak or no oral toxicity. BoNT can tolerate proteolytic 
attack by forming a toxin complex (TC) in which it is conjugated with a 130-kDa 
nontoxic nonhemagglutinin (NTNHA) and/or three types of hemagglutinins 
(HAs) with molecular masses of 70, 33 and 17 kDa (HA-70, HA-33 and HA-17, 
respectively). In particular, the association of BoNT with NTNHA yields an 
amazingly stable complex against acidic and proteolytic conditions, while free-
form BoNT is degraded into small fragments within a few hours in the presence 
of pepsin (Miyata et al., 2009). Additionally, the HAs, especially HA-33, facilitate 
its transport efficiency across intestinal epithelial and aortic endothelial cell 
layers (Niwa et al., 2007; Yoneyama et al., 2008). 
Some studies have indicated that the TC is constructed from its 
constituent molecules in an orderly manner (Hasegawa et al., 2007; Kouguchi et 
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al., 2002; Mutoh et al., 2003). Association of a single BoNT and a single NTNHA 
forms a 280-kDa M-TC. Three HA-70 molecules bind to M-TC via NTNHA 
yielding the 490-kDa M-TC/HA-70. Finally, further conjugation of the three HA-
33/HA-17 complexes (single HA-17 molecule plus two HA-33 molecules) onto 
the M-TC/HA-70 through binding of HA-17 to HA-70 leads to a mature 750-kDa 
L-TC represented by a 14-mer model. The NTNHA molecule plays an important 
role in the assembly pathway that connects BoNT and HAs. Most recently, the X-
ray crystallographic structure of serotype A M-TC was reported (Gu et al., 2012). 
This structure indicated that the NTNHA protein possesses a structure that is 
quite similar to BoNT, and that could be divided into three domains similar to 
BoNT. These domains were designated by reference to those of BoNT, namely 
nLc, nHcN, and nHcC corresponding to the light chain (Lc), the N-terminal 
heavy chain (HcN) and the C-terminal heavy chain (HcC), respectively. The 
crystal structure of M-TC indicated that NTNHA and BoNT form a compact 
interlocked complex. 
In the current study, the author describe the crystal and solution 
structures of NTNHA from C. botulinum serotype D strain 4947 (D-4947) by X-ray 
crystallographic and small-angle X-ray scattering (SAXS) analyses, respectively. 
The data obtained here indicate a discrepancy between the crystal and solution 
structures of the C-terminal part of the NTNHA molecule. This discrepancy may 
explain the interlocking of BoNT and NTNHA to form a stable M-TC structure. 
 
2. MATERIALS AND METHODS 
2.1. Production and purification of M-TC and recombinant NTNHA 
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Production and purification of D-4947 M-TC were performed using a method 
reported previously (Hasegawa et al., 2004; Sagane et al., 2002). TC species were 
purified from culture supernatants by three consecutive chromatographic runs, 
on a TOYOPEARL SP-650S (Tosoh, Tokyo, Japan) cation-exchange column, a 
HiLoad 16/60 Superdex 200 pg (GE Healthcare, Little Chalfont, UK) gel-filtration 
column and a Mono S HR 5/5 (GE Healthcare) cation-exchange column. The 
fractions containing M-TC, identified by SDS- and native-PAGE banding profiles, 
were collected. 
Production and purification of the recombinant NTNHA (rNTNHA; D-
4947) were performed using a method reported previously (Miyata et al., 2009). 
Escherichia coli BL21 cells harboring a pET200/D-TOPO-ntnha vector, in which the 
NTNHA gene is ligated downstream of the 6x His-tag coding sequence, were 
cultured in 20 ml of LB broth containing 100 μg/ml kanamycin at 37°C overnight 
with mild shaking. The culture was inoculated into 800 ml of fresh LB broth and 
cultured at 37°C until the culture reached mid-log-phase. The production of 
rNTNHA was induced by IPTG (0.1 mM). After 18 h incubation at 18°C, cells in 
the culture were collected and suspended in 80 ml of 50 mM phosphate buffer 
(pH 7.4) containing 0.3 M NaCl. The cell suspension was sonicated and 
centrifuged at 10,000g for 20 min at 4°C. The supernatant was suspended with 5 
ml of 50% Ni-Charged Resin suspension (Bio-Rad, Hercules, CA) equilibrated 
with 50 mM phosphate buffer (pH 7.4) containing 0.3 M NaCl. The resin mixture 
was poured into a glass column and rinsed with the same buffer. The bound 
protein was eluted with equilibration buffer containing 300 mM imidazole. The 
eluted fraction containing rNTNHA was precipitated with ammonium sulfate at 
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80% saturation. The pellets were dissolved and dialyzed against 50 mM 
phosphate buffer (pH 6.0) containing 0.15 M NaCl and then applied to a 
Superdex 200 HR 10/30 (GE Healthcare) gel-filtration column equilibrated with 
the same buffer. The purity of the eluted proteins was judged by SDS–PAGE. 
 
2.2. Structural determination and crystallographic refinement of rNTNHA 
X-ray diffraction data of the rNTNHA crystal (Miyata et al., 2012) was integrated 
and scaled using the CrystalClear package (Rigaku, Tokyo, Japan). Subsequent 
data manipulation was carried out using the CCP4 program package. An initial 
phase set was calculated by molecular replacement using MOLREP (Vagin et al., 
1997). The search model for molecular replacement was the structure of NTNHA 
in M-TC from serotype A (PDB code 3V0B), which showed a high sequence 
identity (65.9%) to D-4947 NTNHA. 
Model building was performed using the program Coot (Emsley et al., 
2004), and model refinement was conducted using the program Refmac5 
(Murshudov et al., 1997). Coordinates have been deposited to the Protein Data 
Bank with the accession code: 3VUO. Details of data collection and refinement 
are summarized in Table 1. Figures were prepared with the program CCP4 mg 
(Potterton et al., 2004) and PyMOL (DeLano Scientific). 
 
2.3. Small-angle X-ray scattering analysis 
Small-angle X-ray scattering (SAXS) measurements of the M-TC (5 mg/ml) and 
the rNTNHA (1 mg/ml) in 50 mM acetate buffer (pH 5.0) were carried out on a 
Rigaku BioSAXS-1000 using 10–20 μl of protein solution. A total of eight datasets 
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were collected after 120 min exposure (15 min per data set). Raw data were 
analyzed using the SAXSLab software package (Rigaku). SAXS curves were 
generated after subtracting the scattering due to the solvent in the protein 
solution, using the program PRIMUS (Konarev et al., 2003) from the ATSAS 
package (Petoukhov et al., 2007). 
 
3. RESULTS and DISCUSSION 
3.1. X-ray crystallography of the rNTNHA 
Crystals of the rNTNHA protein were obtained using the hanging-drop vapor 
diffusion method as described previously (Miyata et al., 2012). Diffraction data 
obtained in the report was employed for the determination of X-ray crystal 
structure of the rNTNHA at 3.9-angstrom resolution by molecular replacement 
using the NTNHA structure in serotype A M-TC (Gu et al., 2012). The final model 
(Fig. 1) was refined to an R-factor of 30.10% and a free R-factor of 35.80%. The 
three-dimensional structure of rNTNHA can be divided into three domains 
named nLc, nHcN and nHcC, similar to serotype A NTNHA, as well as all 
serotypes of the BoNT protein, as reported previously (Gu et al., 2012). Most 
recently, we demonstrated that these three domains are closely related to zinc-
dependent metalloproteinase-like, BoNT coiled-coil motif and concanavalin A-
like domains in the SCOP database, respectively (Inui et al., 2012). 
The model includes 1151 amino acid residues, whereas the whole 
NTNHA molecule consists of 1196 amino acid residues. Missing residues are 
Gly114–Gly148, Tyr442–Asp448, Pro1127 and Asp1181–Asn1182. These residues 
are all located in solvent-exposed regions. The X-ray crystal structure of the 
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serotype A NTNHA, which is employed as a template for homology modeling, 
contains two missing regions. These regions correspond to the former two 
missing regions (Gly114–Gly148 and Tyr442–Asp448) in D-4947 NTNHA. In 
earlier studies, the NTNHA molecules produced by native C. botulinum strain D-
4947 (Sagane et al., 2002) and transformed E. coli (Miyata et al., 2009) were found 
to be spontaneously converted to the nicked form via excision of several residues 
at a specific site. The missing region, Gly114–Gly148, was consistent with the 
excised region in the nicked form of NTNHA. The missing residues Tyr442–
Asp448 in D-4947 NTNHA, and the corresponding region in a serotype A 
molecule, would be too flexible in the crystal to be detected by X-ray analysis. 
The remaining two short missing regions (Pro1127 and Asp1181–Asn1182) in D-
4947 NTNHA might have occurred due to gaps in the sequence alignment. 
The NTNHA molecule shares a similar β-trefoil folding at its C-terminal 
(nHcC domain) with the BoNT, HA-33 and HA-17 molecules. β-trefoil folding is 
often found in proteins that function in recognition and binding to 
oligosaccharides, e.g. lectins such as the ricin B chain and Amaranthus caudatus 
agglutinin, and cytokines such as interleukin-1 and fibroblast growth factor 
(Murzin et al., 1992). In a previous study, we demonstrated that cell binding and 
transport across the cell monolayer in the rat intestinal epithelial cell of 
botulinum M-TC (BoNT/NTNHA) and L-TC (M-TC/HAs) arose via BoNT and 
HA-33, respectively, in a sialic acid-dependent manner (Ito et al., 2011). The 
NTNHA molecule may also possess an oligosaccharide recognition ability that 
should be addressed in the near future. Additionally, the nHcC domain displayed 
considerably lower electron density. 
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3.2. Structural dynamics of NTNHA revealed by SAXS image 
The rNTNHA was subjected to SAXS analysis to determine its solution structure. 
The radius of gyration (Rg) and maximum particle dimension (Dmax) of the 
rNTNHA were calculated from SAXS to be 55.52 and 220 angstroms, respectively. 
The rNTNHA crystallographic structure was docked into the SAXS dummy 
residue model (DRM) manually. The SAXS-derived DRM of the rNTNHA with 
the best-fitted crystallographic structure is shown in Fig. 2A. The docking image 
indicated that SAXS DRM could be fitted to the nLc and nHcN domains in the 
crystallographic structure. On the other hand, in this docking image, the nHcC 
domain in the crystallographic structure could not be superposed onto the SAXS 
DRM. Additionally, the author performed SAXS analysis on the D-4947 M-TC 
(BoNT/NTNHA complex). The Rg and Dmax of the M-TC were estimated from 
the SAXS to be 46.76 and 150, respectively. These values were lower than those of 
the NTNHA protein, even though the total molecular mass of M-TC is twice that 
of NTNHA. SAXS DRM of rNTNHA was docked into that of the M-TC manually, 
and the best-fitted image is shown in Fig. 2B. The image clearly demonstrates 
that the extended structure of the rNTNHA model, which resembled a “tail”, 
could not be included in the M-TC SAXS DRM envelope. 
Based on the crystal structure, the inter-domain angles made by axes of 
the HcN and HcC domains were significantly different (∼120 ˚) between serotype 
A/B and E BoNTs (Kumaran et al., 2009), suggesting that the linker between the 
two BoNT domains allows flexibility. Since BoNT and NTNHA share similar 
three-dimensional structures and secondary structure organizations, the linker 
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between nHcN and nHcC should also be flexible. The nLc and nHcN displayed 
very similar appearances in both the crystallographic and the SAXS images, and 
thus these domains would be stationary in solution. On the other hand, the 
remaining area in the SAXS image does not fit to the nHcC domain in the 
crystallographic image. A “wing” like mobility model of the nHcC domain would 
explain this discrepancy. That is, the nHcC domain can iteratively move from an 
orthogonal orientation against the stationary domain, which corresponds to the 
crystallographic image, to a straight, laterally directed orientation. SAXS images 
obtained in this study may represent a merged aspect of the nHcC domain 
swinging around the linker between nHcN and nHcC. However, this model does 
not include the “tail” like extended structure observed in the SAXS image. The 
nHcC domain displayed low electron density in the crystallographic image, 
suggesting flexibility of this domain. The “tail” like aspect in the SAXS image 
may imply an extension of the nHcC domain when it got into a straight lateral 
orientation. The flexibility of the HcC domain in BoNT was also noted previously 
(Schiavo et al., 2000). Gu et al. (2012) demonstrated that serotype A BoNT in M-
TC form (BoNT/NTNHA) displayed a distinct conformation, in contrast to the 
BoNT in free form, in which the HcC domain rotated about 140 ˚ around the 
linker connecting HcN and HcC. Dynamics of the nHcC domain in NTNHA and 
the HcC domain in BoNT may contribute to form the M-TC. Single-molecule 
analysis will be needed to fully understand the dynamics of the NTNHA 
molecule. 
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Figure 1. Crystal structure of the recombinant NTNHA from D-4947. Three 
domains, e.g. nLc in yellow, nHcN in light blue and nHcC in red, were designated 
based on the domain name of BoNT. (A) Crystal structure of the D-4947 NTNHA 
represented by a ribbon diagram. The nicking site due to spontaneous cleavage 
during long-term incubation is indicated by an arrowhead. (B) Ribbon diagram 
of the NTNHA crystal structure that is rotated 90 ˚ clockwise around the y-axis.  
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Figure 2. Crystal and solution structure of the NTNHA. (A) The crystal structure 
image indicated by a three-domain model with nLc in yellow, nHcN in light blue 
and nHcC in red is superimposed onto the solution structure image (blue) 
determined by SAXS. The superposed image implies that the nLc and nHcN 
display a similar form in both the crystal and solution structure, whereas the 
nHcC shows a discrepancy between the crystal and solution structures. (B) 
Solution structure of M-TC and NTNHA. SAXS image of the NTNHA (blue) is 
superposed onto that of the M-TC (red).  
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Figure 3. Hypothetical “wing” model for the NTNHA molecule. The nLc, nHcN 
and nHcC are represented by yellow, light blue and red ellipses, respectively. 
“Most-compressed form” NTNHA model (left) is illustrated based on the crystal 
structure of NTNHA. In the solution structure, the nHcC domain of the NTNHA 
molecule moves like a wing along the axis connecting nHcN and nHcC. 
Movement of the nHcC wing and the “Most-spread form” of the NTNHA (center) 
are based on the solution structure of NTNHA. The combined motions of the 
nHcC wing would be captured as a spread solution structure (right). Elongated 
“tail”-like structure (indicated with dotted lines) observed in the solution 
structure might be due to flexibility of the nHcC domain in solution.  
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SUMMARY 
In this chapter, the author uncovered the three-dimensional structure of the 
NTNHA protein whose crystal structure remained unclear. Here, the NTNHA 
from the serotype D botulinum TC was employed. The NTNHA crystal, prepared 
based on the previous report by Miyata et al (2012), was brought to the X-ray 
crystallographic analysis, and the crystal structure of this protein was 
constructed. As a result, the crystal structure of the NTNHA protein exhibited 
closely similar to that of the BoNT protein. Both proteins are consists of three 
domains, as previous domain architecture prediction by Inui et al (2012) based on 
the in silico analysis. These results indicate that the NTNHA and BoNT may have 
evolved following their branching out from a common ancestral protein. 
Additionally, in this chapter, three-dimensional structure of the NTNHA protein 
in aqueous solution was revealed based on the SAXS analysis. The comparison 
between the crystal and solution structure implies a high flexibility of the C-
terminal third domain of NTNHA protein. The early report demonstrated that 
the BoNT also have a high flexibility domain in the C-terminal third of the 
molecule. Consequently, this clearly indicates an analogy between the NTNHA 
and BoNT protein structural dynamics.  
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II.  Transport of the serotype D NTNHA protein across 
the rat small intestinal epithelial cell monolayer 
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1. INTRODUCTION 
It was recently revealed that NTNHA and BoNT have a similar domain 
architecture comprised of metalloprotease-like, coiled-coil, and concanavalin A-
like domains, implying that both proteins evolved from a common ancestor 
molecule (Inui et al., 2012). This structural similarity is further supported by the 
results shown in chapter I. BoNT, when free from auxiliary nontoxic components, 
binds to and is transported across the cell monolayer of intestinal epithelial cell 
lines (Niwa et al., 2007; Ito et al., 2011; Thirunavukkarasusx et al., 2011). On the 
other hand, NTNHA has not yet been shown to have similar cell binding and cell 
layer transport properties. Based on the structural similarity between these two 
proteins, the author speculated that NTNHA may have similar cell transport 
properties to BoNT. In this study, the cell binding and cell monolayer transport 
properties of serotype D NTNHA were examined using the rat small intestinal 
cell line IEC-6. 
 
2. MATERIALS AND METHODS 
2.1. Production and purification of botulinum toxins 
Clostridium botulinum serotype D strain 4947 was cultured using the dialysis tube 
method (Hasegawa et al., 2004). The culture supernatant was brought to 60% 
saturation with ammonium sulfate, centrifuged, and the resulting precipitate 
dissolved and dialyzed against 50 mM acetate buffer (pH 4.0) containing 0.2 M 
NaCl. The dialysate was then applied to a TOYOPEARL SP-650S (Tosoh, Tokyo, 
Japan) cation exchange column (1.6 × 40 cm) equilibrated with the dialysis buffer. 
The adsorbed protein was eluted with a linear NaCl gradient (0.2–0.8 M). The 
21 
 
fractions containing M-TC, identified by SDS-PAGE and native PAGE, were 
collected, and the protein was precipitated with 80% saturation ammonium 
sulfate. The precipitated M-TC was dissolved in 50 mM acetate buffer (pH 5.0) 
containing 0.15 M NaCl and then applied to a HiLoad 16/60 Superdex 200 pg gel 
filtration column (GE Healthcare, Little Chalfont, UK) equilibrated with the same 
buffer. 
To dissociate the NTNHA and BoNT, the M-TC was dialyzed against 20 
mM Tris-HCl buffer (pH 8.8) containing 0.4 M NaCl. The dialysate was applied 
to a HiLoad 16/60 Superdex 200 pg gel filtration column equilibrated with the 
dialysis buffer. To obtain highly purified BoNT and NTNHA, the BoNT and 
NTNHA fractions were desalted separately by dialysis against 20 mM Tris-HCl 
buffer (pH 8.8) and then applied to a Mono Q HR 5/5 (GE Healthcare) 
equilibrated with dialysis buffer. Elution of the adsorbed protein was performed 
with a linear NaCl gradient concentration (0–0.4 M).    
 
2.2. Cell culture 
The rat small intestine epithelial cell line IEC-6 was obtained from RIKEN 
BioResouse Center (Tsukuba, Japan). Cells were grown in Dulbecco’s modified 
Eagle medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 
penicillin (100 IU/ml) and streptomycin (100 μg/ml). Cells were maintained in a 
humidified environment of 5% CO2 at 37˚C. The culture medium was renewed 
every 2–3 days. 
 
2.3. Antibodies 
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Rabbit polyclonal antibodies were raised against BoNT and NTNHA, 
respectively (Niwa et al., 2007). 
 
2.4. Fluorescent microscopy 
NTNHA and BoNT were labeled with Cy3 (GE Healthcare), according to the 
manufacturer's recommendation. Labeled proteins were separated from free dye 
by column chromatography, and the degree of labeling was determined based on 
the measurements of the Cy3 (absorbance at 552 nm) and protein concentration 
(absorbance at 280 nm). IEC-6 cells were first seeded on a glass chamber slide 
(Nunc A/S, Roskilde, Denmark). For binding assays, cells were incubated with 
Cy3-labeled proteins (80 nM) diluted in Krebs–Henseleit buffer solution (KHB: 
10 mM HEPES, pH 7.0, 130 mM NaCl, 1 mM NaH2PO4, 5 mM KCl, 2 mM CaCl2, 
1 mM MgCl2, 5 mM glucose) for 1 h at 4°C, then rinsed with cold KHB three times 
and fixed with 4% paraformaldehyde for 20 min. The cells were then rinsed with 
KHB three times and incubated with KHB containing DY-490 Phalloidin (10 U 
mL−1; Dyomics GmbH, Jena, Germany) for 1 h. Cells were then observed under a 
fluorescent microscope (Axiovert 40 CFL; CarlZeiss, Jena, Germany) with 
standard FITC excitation/emission filters for DY-490 and rhodamine filters for 
Cy3. 
For the endocytosis assays, cells were incubated with Cy3-labeled 
proteins (200 nM) diluted in KHB for 30 min on ice, then rinsed with cold KHB 
three times. The cells were incubated at 37°C for 10–20 min to allow incorporation 
of the proteins into the cells and then fixed with 4% paraformaldehyde for 20 min. 
After rinsing with KHB three times, they were incubated with KHB containing 
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DY-490 Phalloidin (10 U mL−1) and DAPI (15 μg mL−1; Invitrogen, Carlsbad, CA) 
for 1 h. Cells were analyzed with a Leica TCS laser scanning confocal microscope 
(Plan Apo 63× oil immersion 1.25 NA objective) using leica v2.5 software. 
 
2.5. Western-blot based toxin binding and transport assay 
NTNHA binding to IEC-6 cells and transport through the cell monolayer were 
assayed, as described previously (Niwa et al., 2007) with minor modifications. 
IEC-6 cells were prepared in 24-well dishes (Corning, Corning, NY) and grown 
to confluence. Each protein was suspended in 300 μL of KHB at the indicated 
concentrations and added to culture dishes at 4°C. Cells were then incubated 
with NTNHA for 1 h at 4°C, rinsed three times with cold KHB and lysed with 150 
μL SDS buffer. Proteins bound to cells in 20 μL of the treated sample were 
separated on SDS-PAGE and detected by Western blot analysis. 
For protein transport assays, cells were grown in Transwell culture 
inserts comprised of a two-compartment culture system separated by a 
polycarbonate membrane with a 0.4-μm pore size (Corning). Cells were seeded 
at a confluent density (5.0 × 105 cells cm−2) on the bottom membrane of the culture 
insert. The volumes of culture medium inside and outside of the culture insert 
were 200 and 900 μL, respectively. Cells were cultured for 5 days to allow 
formation of tight connections. NTNHA or BoNT was suspended in 200 μL of 
DMEM containing 5% FBS. Cells were incubated in a 5% CO2 incubator at 37°C. 
The culture medium in the outer chamber was collected and treated with 100 μL 
of 3× SDS buffer. Samples were then subjected to SDS-PAGE and Western blot. 
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2.6. Western blot 
Samples from the binding and transport assays were electrophoresed on 10% SDS 
gels. The separated proteins were blotted onto a nitrocellulose membrane (GE 
Healthcare) and incubated with antibodies diluted 1 : 200 in TBST (20 mM Tris-
HCl buffer, pH 7.5, 150 mM NaCl, and 0.1% Tween) with 5% skimmed milk at 
4°C overnight. After rinsing three times with TBST, the membrane was incubated 
with horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG (Santa Cruz 
Biotechnology, Dallas, TX) diluted 1 : 5000 in TBST containing 5% skimmed milk 
for 1 h at room temperature. After rinsing, proteins were visualized by 
chemiluminescence detection. Goat anti-actin antibody and donkey anti-goat IgG 
antibody conjugated with HRP (Santa Cruz Biotechnology) were used to detect 
actin. 
 
2.7. Measurement of transepithelial electrical resistance and the paracellular 
tracer flux assay 
To examine the integrity of the cell layer, the transepithelial electrical resistance 
(TER) was monitored. The electrical resistance was measured using a Millicell-
ERS Epithelial Volt-Ohm Meter (Millipore, Billerica, MA). Inserts with no cell 
monolayers served as blanks to determine the baseline resistance. The TER (Ω 
cm2) was calculated using the following formula: (TER sample – TER blank) × 
surface area. 
The paracellular flux of FITC-dextran was also assessed to examine the 
integrity of the cell layer. FITC-dextran with molecular mass of 70 kDa (10 μM; 
Sigma-Aldrich, St. Louis, MO) was poured into the apical chamber of the 
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Transwell. After 1-h incubation, the basolateral chamber media were collected, 
and the amount of FITC-dextran in the medium was measured with a 
spectrofluorometer (FP-8200, JASCO, Tokyo, Japan; excitation 495 nm, emission 
510 nm). 
 
3. RESULTS 
NTNHA and BoNT were isolated from the M-TC (a complex of BoNT/NTNHA) 
produced by C. botulinum D-4947. As shown in Fig. 1A, the isolated BoNT and 
NTNHA displayed 150-kDa single and 130- and 115-kDa bands on SDS-PAGE, 
respectively. It was reported that the 130-kDa NTNHA isolated from the D-4947 
M-TC spontaneously converted into a nicked form generating N-terminal 15-kDa 
and C-terminal 115-kDa fragments detectable on SDS-PAGE (Sagane et al., 2001). 
Thus, NTNHA in this sample solution existed as a mixture of both intact and 
nicked forms. 
Purified NTNHA and BoNT were labeled with fluorescent Cy3 dye to 
detect their binding to cells. The moles of dye per mole of labeled protein were 
estimated to be 8.5 for NTNHA and 9.2 for BoNT, based on dye/protein ratios. 
The labeled proteins were added to an IEC-6 cell culture and incubated for 1 h at 
4°C. Concomitantly, the cytoskeletal actin was stained with phalloidin to 
visualize the outline of the cell structure. As a result (Fig. 1B), fluorescence was 
detected from cells treated with Cy3-labeled NTNHA and with BoNT, indicating 
that NTNHA, as well as BoNT, bound to IEC-6 cells. The cells treated with labeled 
proteins were collected, and the fluorescence due to labeled proteins bound to 
the cells was measured using a fluorescence spectrophotometer. As shown in Fig. 
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1C, fluorescence of the Cy3-labeled NTNHA-treated cells increased dose 
dependently. Binding of NTNHA and BoNT was further examined by a Western-
blot-based method. Nonlabeled NTNHA and BoNT (20, 40, and 80 nM) were 
respectively added to an IEC-6 cell culture and then incubated at 4°C for 1 h. 
Proteins bound to the cells were detected by Western blot using anti-NTNHA or 
anti-BoNT. The binding of NTNHA, as well as that of BoNT, increased dose 
dependently (Fig. 1D). 
Endocytosis of Cy3-labeled NTNHA and BoNT into IEC-6 cells was 
analyzed using confocal microscopy. Cells cultured on glass chamber slides were 
exposed to Cy3-labeled NTNHA or BoNT (200 nM) on ice for 30 min to allow 
binding of the proteins to the cells. After rinsing with cold KHB buffer, the cells 
were incubated at 37°C for 10–20 min to initiate internalization of the proteins. 
As shown in Fig. 2, Cy3-labeled NTNHA, as well as Cy3-labeled BoNT, was 
internalized. Interestingly, most of the Cy3-labeled NTNHA and BoNT proteins 
were adjoined to actin. This indicated that intracellular transport of NTNHA and 
BoNT may depend on actin fibers. 
The transports of NTNHA and BoNT were also examined. Each protein 
(80 nM) was poured into the upper chamber of the Transwell that was separated 
by an IEC-6 cell monolayer, and then, protein transported across the layer was 
detected by Western blot (Fig. 3). Both proteins moved across the monolayer in 
an incubation time-dependent manner. This is the first demonstration that 
NTNHA, as well as BoNT, binds to and is internalized by IEC-6 cells and then 
transported across the cell monolayer. 
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4. DISCUSSION 
In a previous study (Inui et al., 2012), it was demonstrated that NTNHA and 
BoNT share a similar domain organization. BoNT may be divided into three 
domains, each of which has a distinct function, for example, the N-terminal 
catalytic domain (light chain; Lc), the central channel-forming domain (N-
terminal half of the heavy chain; HcN), and the C-terminal binding domain (C-
terminal half of the heavy chain; HcC). The C-terminal HcC binding domain of 
BoNT binds to nerve and intestinal epithelial cells (Maksymowych & Simpson, 
2004; Stenmark et al., 2008). Based on in silico analyses (Inui et al., 2012) and 
crystal structures (Gu et al., 2012), NTNHA and BoNT share very similar three-
dimensional structures, and thus, NTNHA can also be divided into three 
domains: N-terminal nLc, central nHcN, and C-terminal nHcC. Additionally, the 
author revealed the structures of NTNHA in crystal and water solution in chapter 
I. However, the functions of these NTNHA domains have not yet been clarified.  
As shown in Fig. 4A, the nHcC domain contains both N-terminal jelly-
roll and C-terminal β-trefoil domains, similar to the HcC domain of BoNT 
(Ginalski et al., 2000). Tetanus neurotoxin (TeNT) and serotypes A and B BoNT 
share the consensus sequence SXWY in the C-terminal β-trefoil domain of the 
HcC, which appears to be responsible for ganglioside-receptor binding on nerve 
cells (Rummel et al., 2004). This SXWY motif is not conserved in NTNHA, nor is 
it conserved in serotypes C and D BoNT (Rummel et al., 2004). These proteins 
share a conserved Trp residue, which is probably responsible for carbohydrate 
binding by the ganglioside-binding loop in the β-trefoil domain (Kroken et al., 
2011). NTNHA does not possess a Trp residue in the loop region corresponding 
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to the ganglioside-binding loop in the HcC-C domain of BoNT. On the other hand, 
the serotype B–F NTNHA possesses a single consensus QXW motif in its nHcC-
C domain, as shown in Fig. 4B. Additionally, serotypes A–D, and F have a 
conserved sequence that is a variant of the known QXW motif, QXY, 50 residues 
upstream from the QXW motif. On the other hand, no serotypes of BoNT possess 
these sequences. The QXW motif is typified by the carbohydrate-binding subunit 
of ricin (Hazes, 1996). Previously, Arndt et al. (2005) explained that NTNHA does 
not bind carbohydrates because it lacks the ganglioside-binding site that is 
shared by TeNT and BoNT serotypes A and B. Therefore, the function of NTNHA 
has been considered to be only protection of BoNT against digestive conditions. 
However, the author found that the serotype D NTNHA molecule binds to IEC-
6 cells. NTNHA also retains the β-trefoil domain and the QXW motif, which are 
both found in a lectin family, and the botulinum HA-33 protein also retains this 
motif (Hazes, 1996).  
Very recently, models of the three-dimensional structure of the serotypes 
A and B L-TC (M-TC/HAs complex) were proposed based on transmission 
electron microscopy images and the crystal structures of its individual 
components (Benefield et al., 2013). This model resembles our model for the three-
dimensional structure of serotype D L-TC (Hasegawa et al., 2007), and it indicates 
that the C-terminal region of NTNHA, which contains candidates for the sugar-
binding sites, is exposed on the surface of the molecule. Similar to the same site 
in NTNHA, the sugar-binding sites in HA-33, HA-70, and BoNT are fully 
accessible in the L-TC model (Benefield et al., 2013). The cell binding and 
transport through the IEC-6 cell layer of the L-TC (M-TC/HA-70/HA-17/HA-33) 
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depend on the number of the HA-33 molecule in the TC, implying that the HA-
33 enhances toxin transport through the intestinal wall (Ito et al., 2011). On the 
other hand, the NTNHA and HA-70 proteins do not facilitate the efficiency of the 
toxin transport (Ito et al., 2011). However, these multiple cell-binding sites, which 
have distinct binding interactions in the TC, may enhance the chances for the 
toxins to access different types of the intestinal epithelial cells. 
 It is still unknown which specific residues are responsible for cell 
binding and transport through the intestinal epithelial cell layer. This will be 
addressed in future studies in which amino acid substitutions are engineered to 
elucidate the pathogenic mechanisms of botulinum toxin delivery in the 
gastrointestinal tract. Such studies should also lead to the eventual design of 
stable oral delivery systems for proteolytically unstable drugs. 
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Figure 1. Binding of the NTNHA and BoNT to the IEC-6 cells. (A) SDS-PAGE 
banding profiles of the NTNHA and BoNT proteins used in this study. The 
proteins were developed on a 13.6% polyacrylamide gel and stained with 
Coomassie Brilliant Blue. The molecular weights of the molecular-weight 
standards (lane 1) are labeled on the left in kilo Dalton. NTNHA (lane 2) 
displayed two bands with molecular weights of 130 and 115 kDa, whereas BoNT 
(lane 3) exhibited a single 150-kDa band. (B) Binding of Cy3-labeled NTNHA and 
BoNT to IEC-6 cells. The cells were incubated with the labeled proteins (80 nM) 
for 1 h at 4°C. Control cells (Cont) were incubated under the same conditions 
without added protein. Actin filaments were visualized with DY-490 phalloidin. 
Original magnification: 200×. Experiments were repeated in triplicate, and 
representative data are shown. Scale bar indicating 50 μm at lower left panel 
applies to all images. (C) Fluorescent measurements of the cells treated with Cy3-
labeled NTNHA and BoNT. The cells cultured in 96-well microplates (Corning) 
were treated with the indicated amounts of Cy3-labeled NTNHA and BoNT for 
1 h at 4°C. The cells were rinsed with KHB and lysed in KHB containing 0.4% 
Triton X-100. The fluorescent intensity was measured at excitation wavelength of 
550 nm and emission wavelength of 570 nm. Experiments were repeated in 
triplicate, and error bars represent the SD. (D) Western-blot-based analysis of cell 
binding. Cells were incubated with NTNHA or BoNT at the indicated 
concentrations for 1 h at 4°C, then lysed with SDS buffer and applied to the SDS-
PAGE followed by Western blotting using an anti-NTNHA or anti-BoNT 
antibody. Experiments were repeated in triplicate, and representative data are 
shown. 
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Figure 2. Internalization of the NTNHA and BoNT in IEC-6 cell. IEC-6 cells 
cultured on a glass chamber slide were exposed to 200 nM Cy3-labeled NTNHA 
or BoNT for 30 min on ice. The slide was then incubated at 37°C for 10–20 min. 
The actin and chromosomes were stained with phalloidin and DAPI, respectively, 
and the specimens were analyzed by confocal microscopy. Experiments were 
repeated in triplicate, and representative data are shown. Scale bar indicates 10 
μm. Images in the left and central panels display confocal sections of the cells 
showing the Cy3 signal (left) and a merged image of Cy3, actin, and 
chromosomal DNA (central). The images in the right panels show 2.7-fold zooms 
of regions indicated by dashed squares in the central panels. 
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Figure 3. Cell layer transport of the NTNHA and BoNT in IEC-6 cells. (A) 
Integrity of the cell layer. Cell monolayers were prepared on semi-permeable 
membranes of Transwell two-chamber systems. The integrity of the cell 
monolayer was examined based on the TER and 70-kDa FITC-dextran fluxes 
through the layer over a 1-h incubation (n = 6, means ± SD). At day 4 of the 
cultivation, the TER reached a maximum and the flux of the dextran through the 
layer was 0.001% of the original solution. (B) NTNHA or BoNT at 80 nM was 
added to the culture medium on the apical side, and cells were incubated for the 
indicated periods of time. Proteins transported through the layer were collected 
from the medium in the basal side and detected by Western blot using an anti-
NTNHA or anti-BoNT antibody. Experiments were repeated in triplicate, and 
representative data are shown. (C) TER measurements during transport of 
NTNHA and BoNT (n = 6, means ± SD). The TER among the untreated, NTNHA-, 
and BoNT-treated monolayer was not significantly different at any time point. 
Cells without BoNT and NTNHA treatment were used as a control. (D) 
Concomitant FITC-dextran (70 kDa) flux during the transport of NTNHA and 
BoNT. In this experiment, FITC-dextran was mixed with an unlabeled NTNHA 
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or BoNT solution (80 nM) and incubated for the indicated time at 37°C (n = 3, 
means ± SD). Cells without BoNT and NTNHA treatment were used as a control. 
The fluxes were slightly increased depending on the incubation time. The 
transported FITC-dextran was below 0.05% of the original solution at 24 h, 
whereas the transported Cy3-labeled NTNHA and BoNT during the 24-h 
incubation were 3.0–5.1% of the original solution (data not shown). 
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Figure 4. The C-terminal third domain (nHcC) of the NTNHA protein. (A) The nHcC domain from the crystal structure of 
D-4947 NTNHA (PDB code 3VUO). The nHcC domain consists of an N-terminal jelly-roll and a C-terminal β-trefoil domain. 
The barrel and cap structures in the β-trefoil domain are indicated. Each β-trefoil repeat is colored with red, green, or blue. 
(B) Multiple alignment of the amino acid sequences of serotype A–F NTNHA proteins. Numbers to the left of each column 
indicate the original residue numbering from the N-termini of the proteins. The β-sheets comprising the β-trefoil repeats in a 
are indicated by red, green, and blue arrows, respectively. Residues highlighted in black, dark gray, and light gray indicate 
100%, 80%, and 60% sequence identity among the serotypes. Closed red circles indicate the location of the QXW sequence 
motif or a variety of the QXW motif.
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SUMMARY 
Botulinum neurotoxin (BoNT) associates with nontoxic nonhemagglutinin 
(NTNHA) yielding a complex in culture. BoNT and NTNHA share similar 
domain organization, implying that they share common function although it 
remains unclear. Here the author examined cell monolayer transport of serotype 
D NTNHA in rat intestinal epithelial cell line IEC-6. The NTNHA, not only BoNT, 
bound to the cell and transported across the cell layer. The NTNHA includes 
QXW motif and β-trefoil fold, widely distributed in sugar chain-recognizing 
proteins, whereas the QXW motif is absent in all BoNT serotypes. This might 
result in distinct sugar chain-recognizing manner of the NTNHA and BoNT. 
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III. Host-cell specificity of the serotype D NTNHA 
protein on the cell-monolayer transport 
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1. INTRODUCTION 
BoNT first forms a heterodimer, termed M-TC, via association with the NTNHA 
protein. Both BoNT and NTNHA are considerably susceptible to proteolytic and 
acid-mediated digestion, yielding small fragments. However, upon formation of 
dimeric M-TC, both BoNT and NTNHA exhibit remarkable stability (Miyata et 
al., 2009). Thus, NTNHA serves to protect BoNT in the digestive tract. However, 
the results obtained in chapter I and another report showed that the domain 
architectures of NTNHA and BoNT are similar, implying that the two proteins 
evolved from the same ancestor (Inui et al., 2012). This means that the proteins 
share functional (and not only structural) similarities. In chapter II, the author 
showed that the serotype D NTNHA molecule bound to and was internalized by 
rat small intestinal epithelial cells prior to transcytosis through this cell layer. In 
the present study, the specificity of NTNHA in terms of cell binding and 
transcytosis through cells was explored using several epithelial and endothelial 
cell lines.  
 
2. MATERIALS AND METHODS 
2.1 Production and purification of NTNHA and BoNT 
The NTNHA and BoNT of the D-4947 strain were synthesized and purified as 
described in chapter II. 
  
2.2 Cell culture 
The rat small intestinal epithelial cell line IEC-6, the human epithelial colorectal 
adenocarcinoma cell line Caco-2, the bovine aortic endothelial cell line BAEC, 
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and the Madin-Darby canine kidney cell MDCK, were obtained from the RIKEN 
BioResource Center (Tsukuba, Japan). Cells were grown in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal bovine serum (FBS), 
penicillin (100 IU mL-1), and streptomycin (100 µg mL-1). When Caco-2 cells were 
cultivated, the medium was additionally supplemented with MEM non-essential 
amino acid solution. Cells were maintained in a humidified environment under 
5% (v/v) CO2 at 37°C and the culture media were changed every 2–3 days. 
 
2.3 Antibodies 
The author used rabbit polyclonal antibodies recognizing NTNHA and BoNT 
(Niwa et al., 2007).  
 
2.4 Confocal analysis of cell-binding, and the cell-entry assay 
NTNHA and BoNT were labeled with Cy5 (GE Healthcare, Little Chalfont, UK) 
according to the manufacturer’s recommendations. Free dye was removed by gel 
filtration. The extent of labeling was determined by measurement of Cy5 levels 
(via absorbance at 650 nm) and protein concentrations (via absorbance at 280 nm).  
Cells were first seeded onto chambered glass slides (Nunc A/S, Roskilde, 
Denmark) and next incubated with Cy5-labeled proteins (200 nM) diluted in 
Krebs-Henseleit buffer (KHB; 10 mM HEPES pH 7.0, 130 mM NaCl, 1 mM 
NaH2PO4, 5 mM KCl, 5 mM NaHCO3, 2 mM CaCl2, 1 mM MgCl2, and 5 mM 
glucose) for 30 min on ice, and rinsed three times with cold KHB. To allow cell 
binding of Cy5-labeled proteins to be observed, cells were fixed in 4% (v/v) 
paraformaldehyde (PFA) for 20 min. To detect endocytosed proteins, cells 
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exposed to the Cy5-labeled proteins (200 nM) diluted in KHB for 30 min on ice 
were incubated with warmed DMEM at 37°C for 10 min to allow protein entry 
into cells, and next fixed in 4% (v/v) PFA. After three rinses in KHB, the cells were 
incubated with KHB containing DY-490 phalloidin (10 U mL-1) and DAPI (15 µg 
mL-1; Invitrogen, Carlsbad, CA) for 1 h. The cells were examined under a Leica 
TCS laser scanning confocal microscope (Plan Apo; 40×; oil immersion; 1.25 NA 
objective), and data were processed with the aid of dedicated Leica software 
(version 2.5). 
 
2.5 Western-blot-based binding and transcytosis assays 
Binding of NTNHA and BoNT to cells, and transcytosis of these proteins through 
cell monolayers, were measured as described in chapter II.  
To estimate protein-binding levels, cells were distributed into 24-well 
culture dishes (Corning Inc., Corning, NY) and grown to confluence. Unlabeled 
proteins were suspended in 300 µL amounts of KHB at various concentrations 
and added to culture dishes chilled to 4°C. Incubation proceeded for 1 h at 4°C, 
and the cells were next rinsed with cold KHB and lysed in 150 µL amounts of 
SDS-PAGE sample buffer. Proteins in 18 µL sample aliquots were separated on 
SDS-PAGE and subjected to Western blotting.  
To evaluate protein transcytosis, cells were grown in Transwell units (for 
BAEC cells [only]; the Transwell filters were fibronectin-coated) featuring a two-
compartment culture system separated by a polycarbonate membrane 0.4 µm in 
pore diameter (Corning). Cells were seeded to confluence (5.0 × 105 cells mL-1) on 
the lower membrane of each insert. The culture volumes below and above the 
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membrane were 900 µL and 200 µL, respectively. Cells were cultured under 
conditions allowing formation of tight connections. To explore the integrities of 
cell layers, both transepithelial electrical resistance (TER) and the extent of 
paracellular flux of FITC-dextran were evaluated, as described in chapter II. 
Unlabeled proteins were suspended in 200 µL amounts of DMEM with 5% (v/v) 
FBS, and test cells were incubated under 5% (v/v) CO2  at 37°C. Culture media in 
outer chambers were collected and admixed with 100 µL amounts of 3× SDS-
PAGE sample buffer prior to SDS-PAGE and Western blotting. Western blotting 
was performed as described in chapter II. 
 
3. RESULTS 
NTNHA and BoNT were independently isolated, under alkaline conditions, from 
the M-TC of C. botulinum D-4947. Purified NTNHA and BoNT were labeled with 
the fluorescent Cy5 dye to facilitate protein detection upon confocal microscopic 
and spectrofluorometric analyses. The molar ratios of dye : protein were 7.7 for 
NTNHA and 9.1 for BoNT, respectively. Labeled proteins were incubated with 
each of four cell lines, (IEC-6, Caco-2, BAEC, and MDCK) for 30 min. Binding of 
labeled proteins was evaluated via confocal microscopy. Cytoskeletal actin was 
simultaneously stained with fluorescent-labeled phalloidin, to allow cell shape 
to be determined. As shown in Fig. 1A, significant signals indicating binding of 
NTNHA and BoNT emanated from the cell surfaces of IEC-6 and BAEC cells. The 
signals from Caco-2 and MDCK cells were also observed although they were 
weaker that those from IEC-6 and BAEC cells. Thus, both NTNHA and BoNT 
bound to all cells employed in this study. These findings were confirmed by 
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analysis of the binding native NTNHA and BoNT (thus, lacking the Cy5 label) by 
Western blotting (Fig. 1B).  
 Entry of the NTNHA/Cy5 and BoNT/Cy5 complexes into cells was 
explored via confocal microscopy. Cells on glass slides were incubated with 200 
nM NTNHA/Cy5, or BoNT/Cy5, on ice, to allow binding. After rinsing with KHB 
to remove excess protein, cells were incubated at 37°C for 10 min to allow 
internalization of bound proteins. As shown in Fig. 2, both NTNHA/Cy5 and 
BoNT/Cy5 were detected in the cytosols of IEC-6 and BAEC cells. However, no 
or weaker signal from NTNHA/Cy5 or BoNT/Cy5 was evident in the cytosols of 
Caco-2 and MDCK cells. Most NTNHA and BoNT molecules were found to be 
adjacent to the cytoskeletal actin of BAEC cells, as noted in chapter II.  
 Transcytosis of NTNHA and BoNT across cell monolayers was then 
examined using the Transwell system. This setup features upper and lower 
chambers separated by monolayers of IEC-6, Caco-2, BAEC, or MDCK cells. The 
integrity of each cell layer was assessed by evaluation of TERs and the extent of 
paracellular FITC-dextran flux (data not shown). The TER of the BAEC cell 
monolayer was significantly lower than that of the other cell monolayers. 
Additionally the paracellular FITC-dextran flux was observed in the BAEC cell 
monolayer, indicating that the BAEC cells could not form tight connections each 
other in vitro. The upper chamber was filled with solutions of native (thus 
unlabeled) proteins (80 nM). After 1, 6, and 24 h of incubation, NTNHA and 
BoNT protein levels in the outer chambers were measured by Western blotting. 
Figure 3A shows that both NTNHA and BoNT were present in the outer 
chambers of Transwells seeded with IEC-6 and BAEC cells, but not when Caco-2 
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or MDCK cells were seeded. Thus, NTNHA and BoNT moved across IEC-6 and 
BAEC monolayers, but not Caco-2 or MDCK monolayers. In summary (Fig. 4B), 
both NTNHA and BoNT bind to and are internalized by IEC-6 and BAEC cells, 
being transcytosed across monolayers of such cells. However, the proteins bind 
to but move across Caco-2 or MDCK monolayers.   
 
4. DISCUSSION 
During bacterial cell culture, NTNHA specifically binds to BoNT, to form a 
heterodimer, termed M-TC, which is remarkably resistant to digestion (Miyata et 
al., 2007); the toxin may thus travel through the digestive tract without being 
degraded. Recently, it was reported that the NTNHA and BoNT of C. botulinum 
are similar in terms of domain architecture (Inui et al., 2012). Such structural 
similarity was further emphasized by elucidation of the crystal structures of the 
NTNHAs of bacteria of serotypes A and D shown in chapter I and another study 
(Gu et al., 2012). The author thus hypothesized that NTNHA and BoNT were 
similar in functional terms. Pure BoNT of serotype A can be absorbed if the toxin 
is injected directly into the stomach or intestine (Maksymowych et al., 1999). 
Additionally, serotype D BoNT can move across a rat intestinal cell monolayer 
(Niwa et al., 2010). In chapter II, the author showed that both the NTNHA and 
BoNT of serotype D were transcytosed across monolayers of rat small intestinal 
epithelial cells (the IEC-6 line). The author thus speculated that NTNHA played 
an important role in toxin transcytosis across the intestinal wall, and did not only 
protect BoNT from the harsh conditions of the digestive tract.  
Of the seven serotypes of the causative bacterium, serotypes C and D are 
44 
 
the predominant agents of animal and avian disease; very few human cases have 
been described (Prevot et al., 1955; Demarchi et al., 1958; Oguma et al., 1990). 
During toxin delivery, the TC must cross the intestinal epithelial cell layer, to 
enter the bloodstream (Fig. 5). As illustrated in Figure 4A, serotype D NTNHA 
and BoNT moved across IEC-6 monolayers, but not those of the human epithelial 
colorectal adenocarcinoma cell line Caco-2. This implies that NTNHA, not only 
BoNT, influences animal susceptibility to toxin, in a serotype-dependent manner. 
 Toxin delivery requires transcytosis of the toxin through not only the 
intestinal wall but also the walls of vessels (Fig. 5). As shown in Figure 4A, neither 
NTNHA nor BoNT moved through monolayers of canine kidney epithelial cells 
(the MDCK line), but did traverse monolayers of bovine aortic endothelial cells 
(BAEC). It was earlier shown that serotype A and C BoNTs were also not 
transcytosed through MDCK monolayers (Maksymowych and Simpson, 1998; 
2004). Such NTNHA specificity in terms of transcytosis through cell monolayers 
may be important in terms of delivery of botulinum toxins. Of the four types of 
cells evaluated in the present study, BAEC monolayers were characterized by 
weak TERs as well as leak of the FITC-dextran (data not shown), indicating that 
these cells could not form tight junctions in vitro. Thus, the extent of NTNHA 
paracellular flux through the intercellular matrix may vary with cell type. 
However, the author confirmed that BAEC cells, not only IEC-6 cells, internalized 
NTNHA (Fig. 2), implying the intracellular transport of the protein in the BAEC 
cells. Thus, this indicates that the NTNHA is able to move across the BAEC cells 
via the intracellular spaces even if the cells form tight junction in vivo.  
 M-TC (a complex of BoNT and NTNHA) dissociates into the two 
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individual components under alkaline conditions in vitro. However, in the 
intestinal tract, the complex does not appear to become dissociated, although the 
TC is exposed to alkaline pancreatic juice prior to entry into the tract (Sakaguchi 
et al., 1984). Therefore, NTNHA may be involved in TC transcytosis through the 
intestinal wall. However, it remains unclear whether BoNT exists in a free or 
complexed form in the bloodstream. It was reported that the dissociation of the 
nontoxic proteins from the BoNT of the TC is incomplete under the physiological 
alkaline pH (pH 7.8) and substantial amounts of the TC are remained as 
complexed form in the BoNT samples (Hasegawa et al., 2004). Such complex may 
be involved in the toxin delivery due to the NTNHA components in the 
bloodstream. Additionally, given that the NTNHA protein is able to pass through 
the intestinal and vessel wall, the protein may be available for delivery system to 
orally transport the protease-susceptible peptide medicine such as insulin, 
because of protease-resistance feature of the NTNHA/BoNT complex (Miyata et 
al., 2009).  
Amatsu et al., (2013) indicated that the HA complex (HA-70/HA-17/HA-
33) from the serotype B disrupts the barrier of intestinal epithelial cell layer after 
translocation of the complex from apical to basal side of the cells (Amatsu et al., 
2013). Otherwise the transcytosis of the NTNHA does not induce the disruption 
of cell layer barrier as shown in Fig 3B. The BoNT and NTNHA share the very 
similar domain architecture in their tertiary structure (Inui et al., 2012; Gu et al., 
2012), whereas the HA-33 does not possess the similarity in the domain 
architecture to BoNT and NTNHA proteins although all proteins possess β-trefoil. 
Consequently the NTNHA and HA would have distinct manner on the 
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transcytosis of the TC across the cell layer. In the barrier disruption model by 
Amatsu et al., the HA-33 and HA-70 in the L-TC (BoNT/NTNHA/HA-70/HA-
17/HA-33) act as binder to the cell and disrupter of the cell-cell connection, 
respectively (Amatsu et al., 2013). On the other hand, the role of the NTNHA on 
the L-TC delivery across the cell layer remained to be clarified. 
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Figure 1. Binding of NTNHA and BoNT to IEC-6, BAEC, Caco-2, and MDCK 
cells. (A) Binding of NTNHA/Cy5 and BoNT/Cy5 to cells incubated with Cy5-
labeled proteins (200 nM) for 30 min on ice. Control cells (Cont.) were incubated 
without added proteins. Actin filaments and chromosomes were visualized by 
staining with DY-490 phalloidin and DAPI, respectively, via confocal microscopy. 
The left images show NTNHA/Cy5 or BoNT/Cy5 signals (gray). On the right, 
images of Cy5 (red), actin (green), and chromosomes (blue), are merged. All 
experiments were performed in duplicate, and representative data are shown. 
Scale bar: 20 µm. (B) Western blot-based analysis of proteins binding to cells 
incubated with unlabeled NTNHA or BoNT, at the indicated concentrations, for 
1 h at 4°C; the cells were next lysed in SDS-PAGE sample buffer and subjected to 
SDS-PAGE followed by Western blotting using an anti-NTNHA or anti-BoNT 
antibody. All experiments were performed in triplicate and representative data 
are shown. In MDCK, nonspecific signals that emerged in dose-independent 
manner appeared as the bands with lower molecular sizes.  
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Figure 2. Internalization of NTNHA and BoNT by IEC-6, BAEC, Caco-2, and 
MDCK cells. Cells cultured on chambered glass slides were incubated with 
NTNHA/Cy5 or BoNT/Cy5 (200 nM) for 30 min on ice, followed by incubation at 
37˚C for 10 min. Internalized proteins were viewed via confocal microscopy. 
Actin filaments and chromosomes were visualized as described in the legend to 
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Figure 1 above. The left images are signals from NTNHA/Cy5 or BoNT/Cy5 
(gray). On the right, images of Cy5 (red), actin (green), and chromosomes (blue), 
are merged. Scale bar: 20 µm. The images in the insets are magnifications of those 
regions delineated by dashed squares in the merged images of IEC-6 and BAEC 
cells.  
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Figure 3. Transcytosis of NTNHA and BoNT through monolayers of IEC-6, 
BAEC, Caco-2, and MDCK cells. (A) Western blot analysis of NTNHA and BoNT 
transcytosis through cell monolayers. NTNHA or BoNT (both at 80 nM) was 
added to the apical sides of monolayers, followed by incubation for the indicated 
periods. NTNHA or BoNT transcytosed to the basal sides of monolayers was 
detected by Western blotting using an anti-NTNHA or anti-BoNT antibody. All 
experiments were performed in triplicate, and representative data are shown. (B) 
TER measurements made during protein transcytosis through cell monolayers 
(n=3, all values are means ± SDs). Monolayers not exposed to NTNHA or BoNT 
treatment served as controls. The TERs of control, and NTNHA- or BoNT-treated 
monolayers, did not differ significantly at any timepoint.   
 
 
A 
B 
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Figure 4. A summary of NTNHA transcytosis through cell monolayers (A), and 
a schematic ligand/receptor model explaining such transcytosis (B). (A) Our 
data suggest that NTNHA protein moves through intracellular spaces in 
monolayers of IEC-6 and BAEC cells (the green checkmarks). However, this is 
not true of Caco-2 and MDCK cells. (B) NTNHA binds weakly to Caco-2 and 
MDCK cells (Fig. 1), but is not internalized by or transcytosed across such cells 
(Figs. 2 and 3). This finding is consistent with the hypothesis that these cells 
possess ligands allowing binding of NTNHA, but not receptors facilitating 
NTNHA transcytosis. However, IEC-6 and BAEC cells have both the ligands and 
the receptors. 
 
 
 
 
✔ 
✔ 
✘ 
✘ 
A B 
53 
 
 
 
 
 
 
 
 
Figure 5. A working model seeking to explain the role played by NTNHA in 
delivery of botulinum toxin. After ingestion of toxin in food contaminated by C. 
botulinum, the toxin enters the stomach. Therein, NTNHA protects BoNT from 
the harsh environment, featuring both proteases and high-level acidity. The toxin 
then reaches the small intestine, from where the toxin enters the bloodstream via 
transcytosis across the intestinal cell wall. NTNHA is proposed to play a role in 
toxin transcytosis across intestinal epithelial cells. Next, the toxin enters the body, 
through vessel walls, in a process facilitated by the cell-binding and transcytosis 
properties of NTNHA. 
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SUMMARY 
In the present work, the author examined the binding and transcytosis of 
serotype D NTNHA protein in epithelial and endothelial cells to clarify the role 
of the protein in toxin delivery. The author showed that NTNHA bound to and 
transcytosed across rat intestinal epithelial (IEC-6) and bovine aortic endothelial 
(BAEC) cells. While NTNHA also bound to canine renal (MDCK) or human colon 
carcinoma (Caco-2) cells, but did not traverse across MDCK or Caco-2 cells. Such 
specificity of NTNHA protein transcytosis may explain how only some animals 
are sensitive to botulinum toxin.  
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ABSTRUCT   
Botulinum neurotoxin (BoNT) is the most potent natural toxin, and the causative 
agent of the botulism. The BoNT is classified into seven serotypes A through G 
based on its antigenicity. Serotypes A, B, E and F BoNTs predominantly cause 
human botulism, whereas the serotypes C and D BoNTs are agents of disease in 
the livestock animal and avian. In nature, the BoNT exists as a part of the toxin 
complex (TC) in which the BoNT is associated with the nontoxic proteins. The 
TC includes the M-TC, a complex of the BoNT and nontoxic nonhemagglutinin 
(NTNHA), and L-TC, a complex of the M-TC and three types of the 
hemagglutinin (HA). Orally ingested botulinum TC run through the 
gastrointestinal tract, and reaches the small intestine. The TC transports across 
the intestinal tract, enters into the blood stream, and the BoNT detached from the 
TC ultimately reaches neuromuscular junction. The BoNT then enters into 
neurons where it cleaves specific protein involved in the neurotransmitter release, 
which results in the interception of the neurotransmission from the neuron to the 
muscle. A series of these process causes a muscle paralysis of human and 
livestock animal, and leads to the botulism disease state.  
Since the discovery of the botulinum TC in the culture fluid of serotype 
A bacterium in 1946, many researchers have been investigating on the botulinum 
TC to clarify its structure and function. Especially, the BoNT protein is the most 
investigated one among the botulinum TC components, because this protein 
exerts the potent toxicity. However, when the BoNT is administered orally to the 
mice, most of the ingested animals survive; even though the intraperitoneal 
administration of the BoNT displays potent lethal activity to the mice. Meanwhile 
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the botulinum TC exerts the potent lethal activity in both cases when 
administered orally and intraperitoneally. Therefore, the nontoxic proteins in the 
botulinum TC is essential for the oral toxicity. To reveal the mechanism of the 
food-borne botulism, it is important to clarify the structure and the function of 
the nontoxic proteins of the botulinum TC. Nevertheless, the structure and 
function of the botulinum TC remains unclear. In particular, three-dimensional 
structure of the NTNHA protein was not uncovered because of the difficulty to 
prepare the NTNHA protein crystal, although the crystal structures of other TC 
components were already revealed.  
Recently, Miyata et al. (2012) succeeded in the crystallization of the 
botulinum NTNHA protein. Additionally the development of the small-angle X-
ray scattering (SAXS) technique provides the relatively easy way to uncover the 
three-dimensional structure of the protein in aqueous solution. In this thesis, the 
author revealed the three-dimensional structure of the NTNHA protein (Chapter 
1). As a result, it was clarified that the NTNHA and BoNT share similar protein 
structure. This finding led us the speculation that the NTNHA and the BoNT 
share the similar function. Based on this speculation, the author investigated the 
interaction between NTNHA and intestinal epithelial cell, and demonstrated the 
transport ability of the NTNHA across the cell monolayer (Chapter 2). Further 
the host-cell specificity on the cell-monolayer transport was also clarified in this 
thesis (Chapter 3).  
 
Chapter I. Three-dimensional structure of the serotype D NTNHA protein 
In this chapter, the author uncovered the three-dimensional structure of the 
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NTNHA protein whose crystal structure remained unclear. Here, the NTNHA 
from the serotype D botulinum TC was employed. The NTNHA crystal, prepared 
based on the previous report by Miyata et al (2012), was brought to the X-ray 
crystallographic analysis, and the crystal structure of this protein was 
constructed. As a result, the crystal structure of the NTNHA protein exhibited 
the very similar to that of the BoNT protein. Both proteins are consists of three 
domains, as previous domain architecture prediction by Inui et al (2012) based 
on the in silico analysis. These results indicate that the NTNHA and BoNT may 
have evolved following their branching out from a common ancestral protein. 
Additionally, in this chapter, three-dimensional structure of the NTNHA protein 
in aqueous solution was revealed based on the SAXS analysis. The comparison 
between the crystal and solution structure implies a high flexibility of the C-
terminal third domain of NTNHA protein. The early report demonstrated that 
the BoNT also have a high flexibility domain in the C-terminal third of the 
molecule. Namely, this clearly indicates an analogy between the NTNHA and 
BoNT protein structural dynamics.  
 
Chapter II. Transport of the serotype D NTNHA protein across the rat small 
intestinal epithelial cell monolayer 
In Chapter 1, the author demonstrated the clear analogies between the NTNHA 
and BoNT structure and structural dynamics. In the previous report, the BoNT 
protein binds to the small intestinal epithelial cell monolayer, and traverses 
across the layer via transcytosis. Because of the structural similarity, it was 
speculated that the NTNHA also has an ability to transport across the cell 
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monolayer. However, the cell-monolayer transport ability of the NTNHA protein 
hitherto had never been described.  
In this chapter, the author examined the cell-monolayer transport ability 
of the serotype D NTNHA protein in the rat small intestinal epithelial cell (IEC-
6). The cell-monolayer transport ability was assessed by following tests: 1) cell-
binding test of the NTNHA to the IEC-6 cells, 2) endocytosis test of the NTNHA 
into the IEC-6 cells, and 3) transport test of the NTNHA across the IEC-6 cell 
monolayer. As results, the NTNHA dose-dependently bound to the IEC-6 cells. 
Further, the NTNHA was endocytosed into the IEC-6 cells, and traversed across 
the cell monolayer. As far as we know, these results indicate the first evidence 
that the NTNHA protein has an ability to move across the intestinal epithelial cell 
monolayer. That is, this implies that the NTNHA, as well as BoNT, can enter into 
the human and animal body via small intestine wall.  
On the other hand, since there are β-trefoil and QXW sequence motifs, both of 
which are commonly found in the lectins, in the C-terminal third of the NTNHA 
crystal structure, the NTNHA protein would bind to the cell via sugar chain on 
the cell surface.  
 
Chapter III. Host-cell specificity of the serotype D NTNHA protein on the 
cell-monolayer transport 
In the previous chapter, the author clarified the cell-monolayer transport ability 
of the NTNHA protein in the IEC-6 cells for the first time. In this chapter, cell-
transport ability of the NTNHA in the several types of cells was examined to 
clarify the host-cell specificity on the cell-monolayer transport of the NTNHA 
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protein. 
Here, the bovine aortic endothelial cell (BAEC), canine renal cell (MDCK), 
and human colon carcinoma (Caco-2) were employed in addition to IEC-6 cell. 
Cell-monolayer transport ability was examined in same manner on previous 
chapter. As results, the serotype D NTNHA bound to all cell types employed. But 
the NTNHA was endocytosed into the IEC-6 and BAEC cells, whereas did not 
into the MDCK and Caco-2 cells. Further, the NTNHA traverses only the cell 
monolayer of the IEC-6 and BAEC. Consequently the NTNHA has an ability to 
move across the intestinal epithelial and vessel endothelial cells, but did not 
across the renal epithelial cell. This implies that the NTNHA is involved in the 
transport of the botulinum TC from the intestinal tract to the vessel and from the 
vessel to tissue fluid (neurons), which are the pathway of the TC transport in the 
animal body. On the other hand, the serotype D NTNHA displayed cell-
monolayer transport in the rat intestinal cell, but did not in the human cell. The 
Serotype D botulinum TC predominantly causes animal botulism, and there is 
only one human botulism case due to the serotype D ever. Since the NTNHA did 
not traverse across the human intestinal cell monolayer, the host-cell specificity 
of the NTNHA protein might determine the sensitivity of the animals to the 
botulinum TC. In conclusion, the findings here implies that the host-cell 
specificity of the NTNHA on cell-monolayer transport might determine the 
transport pathway of TC and sensitive animals to the TC. 
In this thesis, the author revealed the three-dimensional structure of the 
NTNHA protein whose structure and function remained unclear. The unmasked 
structure clearly indicates the structural analogy between the NTNHA and BoNT. 
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Based on this finding, the author speculated the function of the NTNHA protein, 
and demonstrated the cell-monolayer transport ability of the protein. The results 
of the current studies would be an important knowledge to clarify the mechanism 
of the food-borne botulism, and to establish the methods for curing and 
preventing the botulism disease, which occurs in human and livestock animals 
in the world even now. Additionally, the results of this study indicates the 
NTNHA has an ability to traverse across the barrier functions in the living body 
such as wall of intestine and vessel. This function would be useful to construct a 
novel drug delivery system that allows effective transport of the medicines into 
the human or livestock animal body. 
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ABSTRUCT (in Japanese) 
 ボツリヌス神経毒素（Botulinum Neurotoxin; BoNT）は、自然界で最も強い
毒性を示す毒素タンパク質であり、ボツリヌス食中毒の原因物質である。BoNT
は、抗原性の差異により A〜G 型の 7 種に分類され、ヒトでは主に A、B、E お
よび F 型 BoNT、トリやウシなどの家畜では主に C および D 型 BoNT による中
毒例が報告されている。自然界において、BoNT は単独ではなく、無毒タンパク
質と結合した毒素複合体（Toxin Complex; TC）の一部として存在する。TC に
は、BoNT と非毒非血球凝集素（Nontoxic Nonhemagglutinin; NTNHA）が結合
した M-TC と、M-TC に 3 種の血球凝集素（Hemagglutinin; HA）が結合した L-
TC が存在する。経口的に摂取された TC は、胃や腸などの消化管を通過し、小
腸へ運ばれる。小腸に達した TC は、腸管から血管へと移行し、TC から解離し
た BoNT は最終的に神経筋接合部に到達する。BoNT は神経細胞へ侵入し、神経
伝達物質の放出に関与するタンパク質を切断することにより、神経から筋肉へ
の神経伝達を遮断する。これら一連の過程によって、ヒトや家畜の筋肉麻痺が引
き起こされ、ボツリヌス中毒が発症する。 
 1946 年にボツリヌス A 型菌の培養液中から TC が発見されて以来、その構造
や機能に関する研究が世界中で進められている。特に BoNT は、毒性の本体で
あるため、その構造や機能が詳細に解明されている。BoNT をマウスに腹腔内投
与した場合、高い致死率を示すが、BoNT を経口投与すると多くの場合マウスは
生き残る。一方、TC は腹腔内および経口投与のいずれにおいても高い毒性を示
すことから、ボツリヌス食中毒の発生には、BoNT だけでなく、無毒タンパク質
が必須であると考えられる。したがって、ボツリヌス食中毒の発生メカニズムを
明らかにするためには、無毒タンパク質の構造と機能を解明することが重要で
ある。 
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ボツリヌス TC を構成する無毒タンパク質の構造と機能については、未だ不明
な点が多く残されており、特に NTNHA については、試料の調製が困難である
ことなどの理由で、その立体構造が解明されていなかった。しかし、近年、Miyata
ら（2012）が、NTNHA タンパク質の結晶化に成功し、NTNHA の立体構造解
析が可能となった。また、溶液中のタンパク質の立体構造を解析する技術（X 線
小角散乱法; SAXS）の発達により、タンパク質の立体構造解析が比較的容易にな
った。本研究では、まず、NTNHA の立体構造を解析した（第 1 章）。その結果、
NTNHA が、BoNT と類似した構造を持つことが示され、NTNHA は BoNT と
同様の機能を示すことが推測された。この推測を基に細胞学的に NTNHA の性
状を解析し、NTNHA が細胞に結合して透過することを初めて明らかにし（第 2
章）、さらに NTNHA が透過する細胞種の特異性を明らかにした（第 3 章）。 
 
第 1章 D型 NTNHAの立体構造解析 
 本章では、ボツリヌス TC の構成タンパク質のうち、最後までその立体構造が
解明されていなかった NTNHA タンパク質の立体構造を解析した。本実験では、
ボツリヌス D 型菌由来の NTNHA を用いた。Miyata ら（2012）の方法により結
晶化した NTNHA タンパク質の X 線解析を行い、その結晶構造を解析した。そ
の結果、NTNHA の立体構造は BoNT のそれと極めて類似しており、いずれも
3 つのドメインから構成されていることが示された。この結果は、先に Inui ら
（2012）によって示された NTNHA のドメイン構造予測とも一致した。以上の
結果から、BoNT と NTNHA は、共通の祖先タンパク質から進化したタンパク
質であると推測された。さらに、本章では、SAXS により、NTNHA の水溶液中
での立体構造を解明し、結晶中での NTNHA の立体構造と比較した結果から、
NTNHA の C 末端側 1/3 の領域が水溶液中ではフレキシブルな構造を持つこと
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を明らかにした。先に BoNT の C 末端側 1/3 の領域についても同様にフレキシ
ブルな構造を持っていることが明らかにされている。すなわち、NTNHA およ
び BoNT は、そのタンパク質構造ダイナミクスにおいても極めて類似している
ことが示された。 
 
第 2章 D型 NTNHAのラット小腸上皮細胞に対する透過性 
 第 1 章の結果から、NTNHA および BoNT の構造および構造ダイナミクスが
互いに類似していることが示された。先の報告で、BoNT は、小腸上皮細胞と結
合し、トランスサイトーシスによって細胞層を透過することが示されている。し
たがって、構造および構造ダイナミクスが BoNT と類似している NTNHA につ
いても同様に細胞を透過することが推測された。しかし、未だ NTNHA の細胞
透過性については報告されていない。 
本章では、第 1 章と同じく D 型 NTNHA を用い、その培養ラット小腸上皮細
胞（IEC-6）に対する細胞透過性を調べた。なお、NTNHA の細胞透過性につい
ては、1）NTNHA の IEC-6 細胞への結合、2）NTNHA の IEC-6 細胞の内部へ
の取り込み、そして 3）IEC-6 細胞の単層を調製し、NTNHA が細胞層をとうか
するかについて、それぞれ試験を実施した。その結果、NTNHA は濃度依存的
に IEC-6 細胞へ結合した。また、NTNHA の細胞内への取り込み、そして、細
胞層を隔てた NTNHA の移行が観察された。以上の結果は、NTNHA がラット
小腸上皮細胞層を透過することを初めて証明したものである。すなわち、
NTNHA は、動物の体内において物理的なバリアである小腸壁を透過し、体内
に侵入する機能を持つことを示している。 
一方、NTNHA の結晶構造において、その C 末端側 1/3 の領域に、多くのレク
チンに共通してみられるβ-trefoil 構造および QXW 配列が見られたことから、
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NTNHA は、糖鎖を介して細胞に結合する可能性が示唆された。 
 
第 3章 D型 NTNHAが透過性を示す細胞種の特異性 
第 2 章では、NTNHA タンパク質がラット小腸上皮細胞 IEC-6 に対して透過
性を示すことを初めて見出した。本章では NTNHA が透過性を示す細胞を特定
し、その細胞種特異性を明らかにすることを目的とした。  
本章では、培養細胞としてラット小腸上皮細胞 IEC-6 の他に、ウシ大動脈内皮
細胞 BAEC、イヌ腎臓尿細管上皮細胞 MDCK およびヒト大腸癌由来細胞 Caco-
2 を使用した。また、各細胞への透過性は、第 2 章と同じ方法に従い試験した。
その結果、D 型 NTNHA は、試験した全ての細胞に結合した。しかし、NTNHA
の細胞内への取り込みは、IEC-6 および BAEC では見られたが、MDCK および
Caco-2 には取り込まれなかった。さらに、NTNHA の細胞層の透過についても、
細胞内への取り込みと同様、IEC-6 と BAEC にのみ観察された。すなわち、
NTNHA は、腸管上皮および血管内皮細胞に対しては透過性を示し、腎臓上皮
細胞には透過性を示さなかった。このことから、ボツリヌス TC の通過経路であ
る腸管から血管、および、血管から組織液（神経細胞）への移行に NTNHA が
関与していることが示された。一方、D 型 NTNHA は、ラット小腸上皮細胞に
対して透過性を示したが、ヒト大腸上皮細胞に対しては透過性を示さなかった。
D 型ボツリヌス TC は、主にウシなど家畜に対するボツリヌス症の原因物質であ
り、ヒトに対するボツリヌス中毒の発生報告はほとんどない。本研究において、
NTNHA の腸管細胞に対する透過性が、ヒト由来細胞に対して見られなかった
ことから、NTNHA の細胞透過性の特異性が、ボツリヌス TC に対する感受性の
動物種差に関与している可能性が示された。 
 以上の結果、NTNHA がボツリヌス TC の体内での輸送および動物の感受性
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に関与していることが示唆された。 
 著者は、本研究により、ボツリヌス TC 構成成分の中でも、その立体構造およ
び機能性が未だ不明であった NTNHA が、同じ TC の構成成分である BoNT と
極めて類似したタンパク質であることを明らかにした。さらに、その立体構造か
ら、NTNHA の機能を予測し、その細胞層透過性を初めて証明した。本研究の
成果は、ボツリヌス食中毒の発生メカニズムを解明するための重要な知見であ
り、現在でも世界中で発生するヒトおよび家畜のボツリヌス中毒の治療および
予防法の確立につながるものと期待される。 
 また、本研究の結果は、NTNHA が腸管から血管、血管から組織液へと高分
子のまま移行することを示している。この NTNHA の機能を利用し、薬剤の体
内輸送を可能にする新規なドラッグデリバリーシステムへの応用が期待される。 
